Long-Term Correction of Ammonia Metabolism and Prolonged Survival in Ornithine Transcarbamylase-Deficient Mice Following Liver-Directed Treatment with Adeno-associated Viral Vectors
Open Access
- 31 July 2006
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 14 (1) , 25-33
- https://doi.org/10.1016/j.ymthe.2006.03.009
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The role of liver transplantation in urea cycle disordersMolecular Genetics and Metabolism, 2004
- Cognitive outcome in urea cycle disordersMolecular Genetics and Metabolism, 2004
- Long-Term Treatment of Girls with Ornithine Transcarbamylase DeficiencyNew England Journal of Medicine, 1996
- Prolonged Metabolic Correction in Adult Ornithine Transcarbamylase-deficient Mice with Adenoviral VectorsJournal of Biological Chemistry, 1996
- Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.Proceedings of the National Academy of Sciences, 1994
- Assessment of Recombinant Adenoviral Vectors for Hepatic Gene TherapyHuman Gene Therapy, 1993
- Orthotopic liver transplantation for urea cycle enzyme deficiencyHepatology, 1992
- Evaluation of the Transfer and Expression in Mice of an Enzyme-Encoding Gene Using a Human Adenovirus VectorHuman Gene Therapy, 1990
- Risk of serious illness in heterozygotes for ornithine transcarbamylase deficencyThe Journal of Pediatrics, 1986
- Neurologic Outcome in Children with Inborn Errors of Urea SynthesisNew England Journal of Medicine, 1984